Challenges to the Design of Clinical Trials for Live-Attenuated Tetravalent Dengue Vaccines
about
Dengue vaccine: local decisions, global consequencesAn Approach for a Synthetic CTL Vaccine Design against Zika Flavivirus Using Class I and Class II Epitopes Identified by Computer ModelingVaccination with a Leishmania infantum HSP70-II null mutant confers long-term protective immunity against Leishmania major infection in two mice modelsWhich Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Path to a Dengue Vaccine: Learning from Human Natural Dengue Infection Studies and Vaccine Trials.A dose-response study in mice of a tetravalent vaccine candidate composed of domain III-capsid proteins from dengue viruses.
P2860
Challenges to the Design of Clinical Trials for Live-Attenuated Tetravalent Dengue Vaccines
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Challenges to the Design of Cl ...... ed Tetravalent Dengue Vaccines
@ast
Challenges to the Design of Cl ...... ed Tetravalent Dengue Vaccines
@en
Challenges to the Design of Cl ...... ed Tetravalent Dengue Vaccines
@nl
type
label
Challenges to the Design of Cl ...... ed Tetravalent Dengue Vaccines
@ast
Challenges to the Design of Cl ...... ed Tetravalent Dengue Vaccines
@en
Challenges to the Design of Cl ...... ed Tetravalent Dengue Vaccines
@nl
prefLabel
Challenges to the Design of Cl ...... ed Tetravalent Dengue Vaccines
@ast
Challenges to the Design of Cl ...... ed Tetravalent Dengue Vaccines
@en
Challenges to the Design of Cl ...... ed Tetravalent Dengue Vaccines
@nl
P2860
P3181
P1476
Challenges to the Design of Cl ...... ed Tetravalent Dengue Vaccines
@en
P2093
Philip K Russell
Scott B Halstead
P2860
P304
P3181
P356
10.1371/JOURNAL.PNTD.0004854
P407
P577
2016-08-01T00:00:00Z